Association between insulin‐like growth factor‐1 polymorphisms and stomach cancer risk in a Japanese population
Daisuke Ennishi(BC Cancer Agency), Keitaro Matsuo(Aichi Cancer Center), Hidemi Ito(Aichi Cancer Center), Akira Sawaki(Aichi Cancer Center), Miki Watanabe(Nagoya City University), Seiji Ito(Gunma Industrial Technology Center), Yasushi Yatabe(University Hospital Münster), Nobuyuki Hamajima(Nagoya University), Kenji Yamao(Aichi Cancer Center), Satoyo Hosono(Aichi Cancer Center), Kazuo Tajima(Kanagawa University), Kohei Shitara(National Cancer Center Hospital East), Mitsune Tanimoto(Okayama University), Hideo Tanaka(Kyoto Prefectural University of Medicine)
Cited by 22
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Reduced Expression of the <b> <i>let-7</i> </b> MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival
|Cancer Research|2004|2.4k
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2018|1.3k
A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung
|New England Journal of Medicine|2004|839